The USA is testing a competitor to Neuralink: what makes it special.

American startup Precision Neuroscience: competitor to Elon Musk's Neuralink

The Precision Neuroscience studio, based at the Massachusetts Institute of Technology, has received approval from the Food and Drug Administration (FDA) to conduct extended trials of its cortical interface known as Layer 7. This implant contains 1,024 electrodes and can interact with brain activity.

Previous tests of the implant allowed it to be kept in the brain for only one hour, while the new approval permits it to be retained for up to 30 days. This will enable a more detailed study of the device and improve its functionality. Layer 7 is shaped like a thin yellow ribbon that safely adheres to the surface of the brain.

Layer 7 is expected to be useful for surgeons in mapping brain activity and controlling external devices for patients with complex disorders. This technology could be a lifeline for those who have lost the ability to move or speak. Detailed details on the use of the implant in clinical settings are currently being researched.

The achievements of Precision Neuroscience have become a competitor to the already well-known Neuralink project of Elon Musk. It was previously reported that a Swiss brain chip is more effective, but the new cortical interface shows potential to compete with it.